MSL
ABMD

Mackay Shields LLC’s Abiomed Inc ABMD Stock Holding History

Mackay Shields LLC’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,513
Closed -$2.16M – 730
2022
Q1 		$2.16M Sell
6,513
-251
-4% -$77.3K 0.02% 547
2021
Q4 		$2.43M Sell
6,764
-125
-2% -$42.2K 0.02% 533
2021
Q3 		$2.24M Sell
6,889
-201
-3% -$68.1K 0.02% 517
2021
Q2 		$2.21M Sell
7,090
-398
-5% -$122K 0.02% 520
2021
Q1 		$2.39M Sell
7,488
-49
-0.7% -$15.7K 0.02% 691
2020
Q4 		$2.44M Buy
7,537
+59
+0.8% +$16.3K 0.02% 771
2020
Q3 		$2.07M Buy
7,478
+227
+3% +$65.4K 0.01% 777
2020
Q2 		$1.75M Buy
7,251
+242
+3% +$48.6K 0.01% 819
2020
Q1 		$1.02M Sell
7,009
-34
-0.5% -$5.64K 0.01% 937
2019
Q4 		$1.2M Sell
7,043
-431
-6% -$79.9K 0.01% 1028
2019
Q3 		$1.33M Sell
7,474
-12,781
-63% -$2.76M 0.01% 1045
2019
Q2 		$5.28M Sell
20,255
-438
-2% -$116K 0.04% 502
2019
Q1 		$5.91M Sell
20,693
-230
-1% -$76.4K 0.04% 453
2018
Q4 		$6.8M Buy
+20,923
New +$7.27M 0.06% 397
2018
Q3 		– Sell
-18,820
Closed -$7.7M – 1252
2018
Q2 		$7.7M Buy
+18,820
New +$6.82M 0.05% 398

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mackay Shields LLC's ABMD Position: Q2 2022 in Review

Mackay Shields LLC sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 6,513 shares — an estimated $2.16M sold.

Mackay Shields LLC first reported a position in ABMD in Q2 2018 and held it in 15 quarters. The position peaked at $7.7M in Q2 2018. 495 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Mackay Shields LLC reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 6,513 Abiomed Inc shares in Q2 2022, an estimated $2.16M.
  • Mackay Shields LLC first reported a position in Abiomed Inc in Q2 2018 and held it in 15 quarters.
  • Mackay Shields LLC's Abiomed Inc position peaked at $7.7M in Q2 2018.
  • 495 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.